Yuko Kamata

1.4k total citations
48 papers, 976 citations indexed

About

Yuko Kamata is a scholar working on Oncology, Molecular Biology and Obstetrics and Gynecology. According to data from OpenAlex, Yuko Kamata has authored 48 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 13 papers in Molecular Biology and 10 papers in Obstetrics and Gynecology. Recurrent topics in Yuko Kamata's work include Endometrial and Cervical Cancer Treatments (10 papers), Cancer-related Molecular Pathways (8 papers) and Cancer Cells and Metastasis (5 papers). Yuko Kamata is often cited by papers focused on Endometrial and Cervical Cancer Treatments (10 papers), Cancer-related Molecular Pathways (8 papers) and Cancer Cells and Metastasis (5 papers). Yuko Kamata collaborates with scholars based in Japan, United States and France. Yuko Kamata's co-authors include Hiroyuki Kuramoto, Jun Watanabe, Tadayuki Iwase, Yoshimitsu Mizunoe, Akiko Tajima, Shinya Sugimoto, Koji Takada, Toshiko Jobo, Sadamu Homma and Kazumi Hayashi and has published in prestigious journals such as PLoS ONE, JNCI Journal of the National Cancer Institute and Scientific Reports.

In The Last Decade

Yuko Kamata

48 papers receiving 960 citations

Peers

Yuko Kamata
Janina Markowska Poland
Chi‐Chen Fan Taiwan
Haiyang Guo China
Zhongping Cheng China
Yiwei Wang China
Yasushi Yamada Japan
Zhenyu Xiao China
Fangzhou Song China
Sundaramoorthy Revathidevi India
X Chen China
Janina Markowska Poland
Yuko Kamata
Citations per year, relative to Yuko Kamata Yuko Kamata (= 1×) peers Janina Markowska

Countries citing papers authored by Yuko Kamata

Since Specialization
Citations

This map shows the geographic impact of Yuko Kamata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Kamata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Kamata more than expected).

Fields of papers citing papers by Yuko Kamata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuko Kamata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Kamata. The network helps show where Yuko Kamata may publish in the future.

Co-authorship network of co-authors of Yuko Kamata

This figure shows the co-authorship network connecting the top 25 collaborators of Yuko Kamata. A scholar is included among the top collaborators of Yuko Kamata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuko Kamata. Yuko Kamata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsuzuki, Shunsuke, Matthew R. Eber, Yang Yu, et al.. (2024). Crosstalk between bone metastatic cancer cells and sensory nerves in bone metastatic progression. Life Science Alliance. 7(12). e202302041–e202302041. 2 indexed citations
2.
Kamata, Yuko, Toshihide Tanaka, Yohei Yamamoto, et al.. (2023). Prognostic survival biomarkers of tumor-fused dendritic cell vaccine therapy in patients with newly diagnosed glioblastoma. Cancer Immunology Immunotherapy. 72(10). 3175–3189. 6 indexed citations
3.
4.
5.
Iwase, Tadayuki, et al.. (2017). A straightforward assay for measuring glycogen levels and RpoS. Journal of Microbiological Methods. 145. 93–97. 3 indexed citations
6.
Kan, Shin, Shigeo Koido, Masato Okamoto, et al.. (2015). Gemcitabine treatment enhances HER2 expression in low HER2-expressing breast cancer cells and enhances the antitumor effects of trastuzumab emtansine. Oncology Reports. 34(1). 504–510. 25 indexed citations
7.
8.
Koido, Shigeo, Masaki Ito, Yukiko Sagawa, et al.. (2014). Vaccination with vascular progenitor cells derived from induced pluripotent stem cells elicits antitumor immunity targeting vascular and tumor cells. Cancer Immunology Immunotherapy. 63(5). 459–468. 6 indexed citations
9.
Koido, Shigeo, Sadamu Homma, Masato Okamoto, et al.. (2013). Strategies to improve the immunogenicity of anticancer vaccines based on dendritic cell/malignant cell fusions. OncoImmunology. 2(9). e25994–e25994. 11 indexed citations
10.
Kimura, Takahiro, Bungo Furusato, Jun Miki, et al.. (2012). Expression of ERG oncoprotein is associated with a less aggressive tumor phenotype in Japanese prostate cancer patients. Pathology International. 62(11). 742–748. 22 indexed citations
11.
Funamizu, Naotake, Yuko Kamata, Takeyuki Misawa, et al.. (2011). Hydroxyurea Decreases Gemcitabine Resistance in Pancreatic Carcinoma Cells With Highly Expressed Ribonucleotide Reductase. Pancreas. 41(1). 107–113. 16 indexed citations
12.
Kuruma, Hidetoshi, Yuko Kamata, Hiroyuki Takahashi, et al.. (2009). Staphylococcal Nuclease Domain-Containing Protein 1 as a Potential Tissue Marker for Prostate Cancer. American Journal Of Pathology. 174(6). 2044–2050. 64 indexed citations
13.
Arai, Tsutomu, et al.. (2006). Clear cell adenocarcinoma of the endometrium is a biologically distinct entity from endometrioid adenocarcinoma. International Journal of Gynecological Cancer. 16(1). 391–395. 27 indexed citations
14.
Watanabe, Jun, Toshiko Jobo, Yuko Kamata, et al.. (2004). Expression of Tumor Suppressor Gene Product p14ARF in Endometrioid Adenocarcinoma of the Uterine Corpus. International Journal of Gynecological Pathology. 23(3). 234–240. 11 indexed citations
15.
Watanabe, Jun, et al.. (2004). PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus. Journal of Cancer Research and Clinical Oncology. 130(3). 161–168. 42 indexed citations
16.
Kato, Naoya, et al.. (2003). Immunohistochemical expression of cyclin E in endometrial adenocarcinoma (endometrioid type) and its clinicopathological significance. Journal of Cancer Research and Clinical Oncology. 129(4). 222–226. 26 indexed citations
17.
Watanabe, Jun, et al.. (2003). VEGF Expression and its Reguration by p53 Gene Transfection in Endometrial Carcinoma Cells. Human Cell. 16(1). 47–54. 10 indexed citations
18.
Watanabe, Jun, Hiroshi Sato, Yuko Kamata, et al.. (2002). Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus – correlation with proliferation and clinicopathological parameters. British Journal of Cancer. 87(1). 81–85. 46 indexed citations
19.
Watanabe, Jun, et al.. (2001). Stimulatory Effect of Medroxyprogesterone acetate on p27 Protein in Endometrial Cancer Cells. 31(6). 392–397. 1 indexed citations
20.
Saegusa, Makoto, Yasuo Takano, Yuko Kamata, & Isao Okayasu. (1996). Bcl-2 expression and allelic loss of thep53 gene in gastric carcinomas. Journal of Cancer Research and Clinical Oncology. 122(7). 427–432. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Janina Markowska Breakdown of academic impact, for papers by Chi‐Chen Fan Breakdown of academic impact, for papers by Haiyang Guo Breakdown of academic impact, for papers by Zhongping Cheng Breakdown of academic impact, for papers by Yiwei Wang Breakdown of academic impact, for papers by Yasushi Yamada Breakdown of academic impact, for papers by Zhenyu Xiao Breakdown of academic impact, for papers by Fangzhou Song Breakdown of academic impact, for papers by Sundaramoorthy Revathidevi Breakdown of academic impact, for papers by X Chen
Rankless by CCL
2026